folic acid has been researched along with E coli Infections in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PH; Chu, J; Hegemann, JD; Sung, LK | 1 |
| Li, L; Liang, J; Wang, S; Wang, Y; Xu, P; Yi, J; Zhang, M | 1 |
| Chen, X; Cui, Y; Li, W; Ni, J; Shang, F; Xue, T; Yu, L; Zhang, M | 1 |
| Chen, X; Gang, Y; Huang, N; Lin, A; Liu, J; Liu, Y; Long, L | 1 |
| Fakhroueian, Z; Ghaffari, SB; Khorramizadeh, MR; Sarrafzadeh, MH | 1 |
| Dupuis, M; Fairbrother, JM; Gagnon, N; Goulet, J; Lessard, M; Matte, JJ; Nadeau, E | 1 |
| DEVEBER, LL; VALENTINE, GH | 1 |
| Kacprzyk, S; Ochocka, M; Traczewska, M; Zmudzka, B | 1 |
| Sher, N | 1 |
| Allison, ME; Kennedy, AC; McDonald, GA; McGeachie, J | 1 |
| Davogg, S; Watschinger, B | 1 |
| Hitzenberger, G | 1 |
12 other study(ies) available for folic acid and E coli Infections
| Article | Year |
|---|---|
Disrupting Transcription and Folate Biosynthesis Leads to Synergistic Suppression of Escherichia coli Growth.
Topics: Anti-Bacterial Agents; Bacteriocins; Escherichia coli; Escherichia coli Infections; Folic Acid; Humans; Peptides | 2022 |
Biosynthesis of L-5-methyltetrahydrofolate by genetically engineered Escherichia coli.
Topics: Escherichia coli; Escherichia coli Infections; Folic Acid; Humans; Tetrahydrofolates | 2022 |
Autoinducer2 affects trimethoprim-sulfamethoxazole susceptibility in avian pathogenic Escherichia coli dependent on the folate synthesis-associate pathway.
Topics: Animals; Chickens; Columbidae; Ducks; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Folic Acid; Gene Expression Regulation, Bacterial; Homoserine; Lactones; Methyltransferases; Poultry Diseases; Quorum Sensing; Repressor Proteins; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Calcium Phosphates; Cell Membrane; Drug Carriers; Drug Compounding; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Folic Acid; Genes, MDR; Hydrogen-Ion Concentration; Mice; Nanoparticles; Rhodamines; Silicon Dioxide; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Static Electricity; Wound Healing | 2018 |
Flower-like curcumin-loaded folic acid-conjugated ZnO-MPA- βcyclodextrin nanostructures enhanced anticancer activity and cellular uptake of curcumin in breast cancer cells.
Topics: 3-Mercaptopropionic Acid; Antineoplastic Agents; Apoptosis; beta-Cyclodextrins; Breast Neoplasms; Cell Line, Tumor; Curcumin; Drug Carriers; Escherichia coli; Escherichia coli Infections; Female; Folic Acid; HEK293 Cells; Humans; Nanostructures; Staphylococcal Infections; Staphylococcus aureus; Zinc Oxide | 2019 |
Administration of Pediococcus acidilactici or Saccharomyces cerevisiae boulardii modulates development of porcine mucosal immunity and reduces intestinal bacterial translocation after Escherichia coli challenge.
Topics: Animals; Animals, Suckling; Escherichia coli; Escherichia coli Infections; Female; Folic Acid; Ileum; Immunity, Innate; Immunity, Mucosal; Immunoglobulin A; Intestines; Leukocyte Count; Lymph Nodes; Pediococcus; Probiotics; Random Allocation; Saccharomyces cerevisiae; Swine; Vitamin B 12 | 2009 |
NITROFURANTOIN AND MEGALOBLASTIC ANAEMIA.
Topics: Anemia; Anemia, Hemolytic; Anemia, Macrocytic; Anemia, Megaloblastic; Diagnosis; Escherichia coli Infections; Folic Acid; Folic Acid Deficiency; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Nitrofurantoin; Toxicology; Urinary Tract Infections | 1964 |
[Folic acid activity in acute infections in children].
Topics: Acute Disease; Child, Preschool; Diarrhea, Infantile; Escherichia coli Infections; Folic Acid; Humans; Infant; Infections; Otitis; Respiratory Tract Infections; Sepsis; Staphylococcal Infections; Urinary Tract Infections | 1981 |
Prophylactic chemotherapy with low-dosage trimethoprim-sulfamethoxazole following acute urinary tract infections in children.
Topics: Ampicillin; Bacterial Infections; Child; Child, Preschool; Drug Combinations; Drug Evaluation; Escherichia coli Infections; Folic Acid; Humans; Infant; Methenamine; Nitrofurantoin; Proteus Infections; Recurrence; Streptococcal Infections; Sulfamethoxazole; Trimethoprim; Urinary Tract Infections | 1975 |
Sulphamethoxazole-trimethoprim therapy in urinary tract infection with reference to its haematological effects.
Topics: Adolescent; Adult; Aged; Blood Cell Count; Drug Resistance, Microbial; Drug Synergism; Escherichia coli Infections; Female; Folic Acid; Folic Acid Antagonists; Hemoglobins; Humans; Klebsiella Infections; Middle Aged; Proteus Infections; Sulfamethoxazole; Urinary Tract Infections | 1969 |
[First experience with a combined chemotherapeutic agent in pyelonephritis].
Topics: Adolescent; Adult; Aged; Aminobenzoates; Anti-Bacterial Agents; Antimetabolites; Bacteriuria; Drug Synergism; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Folic Acid; Folic Acid Antagonists; Humans; Male; Middle Aged; Proteus Infections; Pyelonephritis; Pyrimidines; Staphylococcal Infections; Streptococcal Infections; Sulfamethoxazole | 1970 |
[Chemotherapeutic results in chronic pyelonephritis with a combination of trimethoprim with sulfamethoxazole (Eusaprim)].
Topics: Aminobenzoates; Anti-Bacterial Agents; Drug Synergism; Escherichia coli Infections; Folic Acid; Folic Acid Antagonists; Humans; Proteus Infections; Pyelonephritis; Pyrimidines; Sulfamethoxazole | 1970 |